paclitaxel has been researched along with Vaginal Fistula in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Colombo, N; Donica, M; Dreosti, L; Estevez-Diz, M; Gonzalez-MartÃn, A; Irahara, N; Joly, F; Lorusso, D; McCormack, M; Nogueira-Rodrigues, A; Redondo, A; Ruff, P; Scambia, G; Schenker, M | 1 |
1 trial(s) available for paclitaxel and Vaginal Fistula
Article | Year |
---|---|
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancer.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carboplatin; Drug Administration Schedule; Female; Humans; Incidence; Intestinal Fistula; Intestinal Perforation; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Paclitaxel; Progression-Free Survival; Uterine Cervical Neoplasms; Vaginal Fistula; Young Adult | 2020 |